Cardiology devices: market revenue Mexico 2016-2028

The revenue of the cardiology devices segment of the medical technology market in Mexico was forecast to continuously increase between 2024 and 2028 by in total 315.5 million U.S. dollars (+24.71 percent). After the eighth consecutive increasing year, the indicator is estimated to reach 1.6 billion U.S. dollars and therefore a new peak in 2028.

Revenue of the cardiology devices market in Mexico from 2016 to 2028 (in million U.S. dollars)

Characteristic	Revenue in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

More information

Supplementary notes

Data provided by Statista Market Insights are estimates.

Definition:
The cardiology devices market includes diagnostic, monitoring, and surgical devices that are used to treat heart diseases and heart-related problems.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Abbott Laboratories, Boston Scientific, Edwards Lifesciences.
Further information on the key players can be found in the Market Shares boxes.

Citation formats